Core Viewpoint - A class action lawsuit has been filed against Stride, Inc. for securities fraud, following significant stock drops attributed to alleged violations of federal securities laws [1][3]. Company Overview - Stride, Inc. is an education technology company that provides an online platform for students across the U.S. [4]. Allegations - The lawsuit claims that Stride inflated enrollment numbers by retaining "ghost students," failed to comply with employee background checks and licensure laws, and provided a poor customer experience leading to higher withdrawal rates and lower conversion rates [4][5]. Stock Performance - On September 14, 2025, Stride's stock dropped by $18.60, or over 11%, from $158.36 to $139.76 per share following the fraud allegations [5]. - On October 28, 2025, Stride admitted to issues with customer experience, resulting in an estimated 10,000-15,000 fewer enrollments, causing the stock to plummet by $83.48, or more than 54%, from $153.53 to $70.05 per share [6]. Legal Proceedings - Investors have until January 12, 2026, to request to lead the case in the U.S. District Court for the Eastern District of Virginia [3]. - The lawsuit is titled MacMahon v. Stride, Inc., et al., No. 1:25-cv-02019 [3]. Investor Actions - Investors are encouraged to submit their information to the law firm representing the class action, with no upfront costs for shareholders [8].

FCX LAWSUIT: Freeport-McMoRan Inc. Investors are Notified to Contact BFA Law about the Filed Securities Fraud Class Action and Important January 12 DeadlineNovember 19, 2025 3:36 PM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - November 19, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Freeport-McMoRan Inc. (NYSE: FCX) and certain of the Company's senior executives for securities fraud aft ...

Core Viewpoint - A class action lawsuit has been filed against James Hardie Industries plc for securities fraud, following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Northern District of Illinois, with a deadline of December 23, 2025, for investors to seek lead plaintiff status [3]. - The complaint alleges violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in James Hardie common stock [3]. Group 2: Company Background - James Hardie is a producer and marketer of high-performance fiber cement building solutions, primarily used in external siding for the residential building industry in the U.S. and Canada [4]. Group 3: Allegations of Fraud - During the relevant period, James Hardie claimed strong performance in its North American fiber cement segment, asserting "inherent strength" and "underlying momentum" in its strategy [5]. - The lawsuit alleges that the reported sales were due to inventory loading by channel partners rather than genuine customer demand, indicating potential fraudulent practices [5]. Group 4: Stock Performance - On August 19, 2025, James Hardie disclosed a 12% decline in North American fiber cement sales, leading to a stock price drop of $9.79 per share, or over 34%, from $28.43 to $18.64 [6].

Core Viewpoint - A class action lawsuit has been filed against CarMax, Inc. for securities fraud following a significant drop in stock price attributed to potential violations of federal securities laws [2][4]. Group 1: Lawsuit Details - The lawsuit is led by Bleichmar Fonti & Auld LLP and claims violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [4]. - Investors have until January 2, 2026, to request to lead the case, which is pending in the U.S. District Court for the District of Maryland [4]. Group 2: Financial Performance - CarMax reported disappointing financial results for Q2 of fiscal year 2026, including a 5.4% decline in retail used unit sales, a 6.3% decline in comparable store used unit sales, and a 2.2% decline in wholesale units [7]. - The company's net income for Q2 was approximately $95.4 million, down from $132.8 million in the previous year [7]. Group 3: Stock Price Impact - Following the financial results announcement on September 25, 2025, CarMax's stock price dropped by $11.45 per share, or roughly 20%, from $57.05 to $45.60 [8]. - The unexpected departure of CEO Bill Nash on November 6, 2025, and a weak preliminary Q3 outlook led to an additional stock price drop of over 24% [8]. Group 4: Company Operations - CarMax's previous claims of strong and sustainable demand for its cars were allegedly misleading, as the demand surge was primarily due to customers purchasing vehicles before the imposition of U.S. tariffs [5][6].

Core Viewpoint - Ardent Health, Inc. is under investigation for potential violations of federal securities laws due to improper accounting practices related to accounts receivable and professional liability reserves [1][3]. Financial Performance - On November 12, 2025, Ardent reported a $43 million decrease in revenue for Q3 2025 after conducting "hindsight evaluations of historical collection trends" [4]. - The company also increased its professional liability reserves by $54 million due to adverse claim developments from 2019 to 2022 and broader industry trends [4]. Stock Market Reaction - Following the financial report, Ardent's stock price dropped over 33% during trading on November 13, 2025 [4].

Core Viewpoint - A lawsuit has been filed against MoonLake Immunotherapeutics for potential violations of federal securities laws, with a significant deadline for investors to act by December 15, 2025 [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of New York, captioned Peters v. MoonLake Immunotherapeutics, et al., No. 1:25-cv-08612 [3]. - Investors are encouraged to contact BFA Law for more information and to potentially lead the case [2][8]. Group 2: Company Background - MoonLake Immunotherapeutics is a clinical-stage biotechnology company focused on developing therapies for inflammatory diseases [4]. - The company conducted Phase 3 VELA trials for sonelokimab (SLK), aimed at treating moderate to severe hidradenitis suppurativa [4]. Group 3: Allegations and Impact - The complaint alleges that MoonLake misrepresented its clinical data and the benefits of SLK's Nanobody structure compared to traditional monoclonal antibody treatments [5][6]. - Following the announcement of disappointing results from the VELA trials on September 28, 2025, MoonLake's stock price plummeted nearly 90%, from $61.99 to $6.24 per share [7].

Core Viewpoint - A class action lawsuit has been filed against Synopsys, Inc. for securities fraud, following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Company Overview - Synopsys, Inc. specializes in design automation software products used for designing and testing integrated circuits. Its Design IP segment, which provides pre-designed silicon components, has been the fastest-growing segment, increasing from 25% of revenue in 2022 to 31% in 2024 [4]. Financial Performance - In Q3 2025, Synopsys reported a revenue of $425.9 million for its Design IP segment, reflecting a 7.7% decline year-over-year. The net income was $242.5 million, marking a 43% year-over-year decline [6]. Customer Dynamics - The lawsuit alleges that contrary to Synopsys's claims of strong customer reliance and market strength, its Design IP customers began requiring more customization, negatively impacting the economics of the Design IP business and threatening its business model [5]. Stock Market Reaction - Following the release of disappointing Q3 2025 results, Synopsys's stock price fell from $604.37 per share to $387.78 per share, a decline of nearly 36% in one day [6].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Hormel Foods Corporation due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation Details - The investigation is prompted by a Wall Street Journal article published on October 29, 2025, which reported that Hormel Foods cut its earnings forecast due to price pressures, bird flu, and a fire at its Arkansas peanut butter production facility [3]. - Following the news, Hormel Foods' stock experienced a significant decline of 9.1% on the same day [3]. Group 2: Class Action Information - Shareholders who purchased Hormel securities may be entitled to compensation through a class action lawsuit, with no out-of-pocket fees or costs due to a contingency fee arrangement [2]. - Interested investors can join the prospective class action by visiting the provided link or contacting the law firm directly [2]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and consistently ranking among the top firms for securities class action settlements since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for its clients [4].

New York, New York--(Newsfile Corp. - November 19, 2025) - Bronstein, Gewirtz & Grossman, LLC and KND Complex Litigation are investigating potential claims on behalf of purchasers of Ag Growth International Inc. ("Ag Growth" or "the Company") (TSX: AFN). Investors who purchased Ag Growth securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/AFN.Investigation DetailsOn November 13, 2025, after hours, Ag Growth issued a news release an ...

Core Insights - The event "What Investors Want: Driving Growth Through Purpose and Performance" focuses on how ESG performance influences investment decisions, highlighting the increasing expectations from investors regarding sustainability [1][2]. Event Details - The event is scheduled for November 25, 2025, at TELUS Harbour in Toronto, with registration starting at 8:00 a.m. ET and the program running from 8:45 a.m. to 12:00 p.m. ET [2]. - The event is organized by the UN Global Compact Network Canada in collaboration with the Principles for Responsible Investment (PRI) [1][2]. Participants and Speakers - Notable speakers include Jane Ambachtsheer from BNP Paribas Asset Management, Wendy Berman from the Canadian Sustainability Standards Board, and Anna Murray from the Ontario Teachers' Pension Plan, among others [4]. Initiative Background - Canada Climate Week Xchange (CCWX) is a five-year initiative aimed at addressing climate-related challenges in Canada, encouraging collaboration among various organizations and individuals [5].